Breaks Categories: News

WednesdayFeb 26, 2020 12:34 pm

NetworkNewsBreaks – Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) Featured in ROTH Equity Research Report

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “This morning, ALNA announced proposed changes to URIROX-2, including reduction of overall EH patients (200 vs. 400) and adding an interim analysis of 130 patients at six months treated expected 3Q21, with full readout for BLA filing in 1Q22. As discussed in our report below, we believe strong stat. sig. UOx reductions from URIROX-1 and KS rates reduce risk from decreasing the number patients studied. Importantly, we see streamlining as limiting any financial overhang (~1/3 the cost of…

Continue Reading

WednesdayFeb 26, 2020 12:22 pm

NetworkNewsBreaks – Evolus, Inc. (NASDAQ: EOLS) Featured in Mizuho Securities Research Report

Evolus, Inc. (NASDAQ: EOLS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Evolus reported full 4Q19 results today that were solid but largely expected following the company's pre-announcement on Jan 9. We maintain our BUY rating on EOLS shares as we expect the company to continue to execute on the commercialization of Jeuveau in a highly attractive facial toxin market. However, we appreciate that investors remain concerned about the ongoing legal issues between their partner Daewoong and competitor Medytox over Jeuveau’s development and that will remain an overhang for the stock,…

Continue Reading

WednesdayFeb 26, 2020 11:43 am

NetworkNewsBreaks – Xencor, Inc. (NASDAQ: XNCR) Featured in Mizuho Securities Research Report

Xencor, Inc. (NASDAQ: XNCR) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “XNCR's 4Q19 EPS update was largely in line with our thesis as we see 2020 as a year of gaining visibility on the critical paths for wholly-owned T-cell engagers (TCEs), most notably plamotamab for B cell malignancies, which showed potential for advancement at ASH this past year. We see the next steps for plamotamab as locking down dose and schedule in 2020, and we expect incremental news from other pipeline candidates, which we see as valuation expansion opportunities. 4Q19…

Continue Reading

WednesdayFeb 26, 2020 11:15 am

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Featured in Mizuho Securities Research Report

Revance Therapeutics, Inc. (NASDAQ: RVNC) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Revance reported earnings yesterday. 4Q19 EPS of $(0.99) was slightly below FactSet consensus of $(0.95) which we believe it is immaterial for a developmental stage Biotech company. The PDUFA date for DAXI in glabellar lines is 11/25/2020, and important data catalysts are expected throughout 2020. We continue to see RVNC shares as attractive today given the overall growth opportunities in neuromodulators and facial fillers, as well as further upside from the company's therapeutics pipeline.” To request access to…

Continue Reading

WednesdayFeb 26, 2020 10:39 am

NetworkNewsBreaks – Applied Genetic Technologies Corp. (NASDAQ: AGTC) Secures $37.4M in Underwritten Public Offering

Applied Genetic Technologies (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (“AAV”)-based gene therapies for the treatment of rare diseases, has closed an underwritten public offering. According to the update, the offering consisted of 7,475,000 shares of its common stock, including an additional 975,000 shares pursuant to the full exercise of the over-allotment granted to the underwriters. Applied Genetic Technologies secured gross proceeds of approximately $37.4 million, with each of the shares sold at the public offering price of $5.00. ROTH Capital Partners acted as co-manager for the offering. To request access to the full report,…

Continue Reading

WednesdayFeb 26, 2020 10:17 am

NetworkNewsBreaks – Choom(TM) Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Announces Opening of Next Licensed Cannabis Retail Store in Calgary, Alberta

Choom(TM) (CSE: CHOO) (OTCQB: CHOOF), one of Canada's leading recreational cannabis retailers, on Tuesday announced the opening of its next licensed cannabis retail store in Calgary, AB. The store, opening in the bedroom community of Shawcliffe, is Choom’s first retail store to open in Calgary, as well as its 14th store in Alberta and 15th location in Canada. “We are very pleased to be opening our first location in the City of Calgary,” Choom CEO Corey Gillon said in the news release. “This new location is another example of the continued commitment to our growth strategy and the vision of…

Continue Reading

WednesdayFeb 26, 2020 9:49 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Awarded Contract by Leading Research Institution Mississippi State University Center for Advanced Vehicular Systems

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been awarded a contract by the Mississippi State University Center for Advanced Vehicular Systems (“CAVS”), a world-class interdisciplinary research center that uses state-of-the-art technology to address engineering challenges facing U.S. mobility industries. Per the update, CAVS will install PrinteRite3D on a Renishaw AM400 machine, a new OEM platform for Sigma Labs, further proving the interoperability potential of PrintRite3D's platform to an increasingly large machine base. Under the agreement, in addition to any PrintRite3D(R) research or commercial applications, CAVS…

Continue Reading

WednesdayFeb 26, 2020 9:22 am

NetworkNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Appoints New Member to Board of Directors

Spectrum Global Solutions (OTCQB: SGSI), a leading single source energy management technology and network services provider, on Tuesday announced the appointment of prominent legal expert Brynjar N. Meling to the company’s Board of Directors. Meling is the chairman and owner of the Meling AS law firm in Norway and has previously served as a board member of Spectrum’s WaveTech GmbH subsidiary. “We are privileged that Brynjar has accepted this appointment and for his continued support of our company,” Spectrum Global Solutions CEO Roger Ponder stated in the news release. “Brynjar’s professional background, experience and in-depth knowledge of WaveTech enables him…

Continue Reading

TuesdayFeb 25, 2020 12:57 pm

NetworkNewsBreaks – McEwen Mining Inc. (NYSE: MUX) Featured in ROTH Equity Research Report

McEwen Mining (NYSE: MUX) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Positive exploration results at Grey Fox continue to roll in. We note that the early focus of the company's 2020 exploration campaign appears to be on the Grey Fox property, which hosts six distinct targets. We believe recent exploration results support to the potential for an increase in the project's resource base once an update is released in 1Q20. As such, we are reiterating a Buy rating and $3.00 price target.” To request access to the full report, visit…

Continue Reading

TuesdayFeb 25, 2020 12:55 pm

NetworkNewsBreaks – Gaia, Inc. (NASDAQ: GAIA) Featured in ROTH Equity Research Report

Gaia (NASDAQ: GAIA) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We expect 4Q results could be slightly better than consensus, with GAIA reaching a full quarter of adj. EBITDA profitability and continued cash burn reductions. We believe benefits from referral programs and live event/premium offering scaling should aid organic additions and ARPS, which should set GAIA up to see a re-acceleration in topline growth and expanding EBITDA margins in FY20. Overall, we believe the stock set up remains favorable going into 4Q results/FY20 as it approaches positive potential FCF.” To…

Continue Reading